glp 1 from china Chinese Companies Are Developing Advanced GLP-1 Drugs China approves first home-grown GLP-1

Spermatogenesis and steroidogenesis disruption in a model of metabolic syndrome rats

A 2023 meta-analysis found that NAC improved some metabolic markers in women with PCOS, including fasting glucose.21 More recent research has also explored NAC alongside ovulation-induction treatments, suggesting possible benefits for endocrine and reproductive outcomes.20 While the findings are encouraging, researchers are still working to determine which women are most likely to benefit and how NAC compares with established treatments such as metformin

However, observational data and mechanistic reasoning suggest additive glucose-lowering effects without major pharmacokinetic interactions

Acknowledgements We appreciated the participants and their families and all academic personnel of the Imam Reza Hospital and the Mashhad University of Medical Sciences, Mashhad, Iran, for their kind cooperation